Heartburn medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 49: Line 49:
{{Reflist|2}}
{{Reflist|2}}


 
[[Category:General practice]]
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Bacterial diseases]]
[[Category:Digestive disease symptoms]]
[[Category:Pulmonology]]
[[Category:Needs overview]]

Revision as of 20:00, 6 September 2020

Heartburn Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Heartburn from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT-Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Heartburn medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Heartburn medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onHeartburn medical therapy

CDC on Heartburn medical therapy

Heartburn medical therapy in the news

Blogs on Heartburn medical therapy

Directions to Hospitals Treating Heartburn

Risk calculators and risk factors for Heartburn medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2] José Eduardo Riceto Loyola Junior, M.D.[3]

Overview

The treatment of heartburn in the setting of GERD is lifestyle modifications which include weight loss, elevating head of the bed and no eating before going sleep. The pharmacologic medical therapy is recommended among patients with persistent GERD despite following the lifestyle modifications. Antacids, histamine receptor antagonists, proton pump inhibitors, and prokinetics medications are used in treatment of GERD.

Medical Therapy

Gastroesophageal reflux disease

Lifestyle Modifications

  • The following measures are recommended as the first line to treat GERD:[1][2][3][4]
    • Weight loss
    • Elevating head of the bed
    • No eating two hours before going sleep
  • Avoidance of the following foods and lifestyles is recommended in treatment of GERD:

Medical therapy

  • The medical therapy is indicated for the patients who have persistent GERD regardless the lifystyle and food modifications.[5][6]
  • The following medical therapies are strongly recommended by the American College of Gastroenterology:
    • Antacids Antacids work by neutralizing excess stomach acid. Antacids provide fast relief of symptoms, but relief typically lasts for just 30-60 minutes. There may be rebound pain after its effect is over:
    • Histamine-receptor antagonists (H2RA):
      • Preferred regimen (1): Ranitidine 150 mg q12 daily PO
      • Preferred regimen (2): Cimetidine 400 mg q6h or 800 mg q12 PO for 12 weeks
      • Preferred regimen (3): Famotidine 20 mg q12 PO for 6 weeks
    • Proton pump inhibitors:
      • Preferred regimen (1): Omeprazole 20 mg q24 PO for up to 4 weeks
      • Preferred regimen (2): Esomeprazole 20 mg or 40 mg q24 IV
    • Prokinetic medications:

Medical therapy for other causes of heartburn or similar clinical features

References

  1. Piesman M, Hwang I, Maydonovitch C, Wong RK (2007). "Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter?". Am. J. Gastroenterol. 102 (10): 2128–34. doi:10.1111/j.1572-0241.2007.01348.x. PMID 17573791.
  2. Kaltenbach T, Crockett S, Gerson LB (2006). "Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach". Arch. Intern. Med. 166 (9): 965–71. doi:10.1001/archinte.166.9.965. PMID 16682569.
  3. Ness-Jensen E, Hveem K, El-Serag H, Lagergren J (2016). "Lifestyle Intervention in Gastroesophageal Reflux Disease". Clin Gastroenterol Hepatol. 14 (2): 175-82.e1-3. doi:10.1016/j.cgh.2015.04.176. PMC 4636482. PMID 25956834.
  4. Khoury RM, Camacho-Lobato L, Katz PO, Mohiuddin MA, Castell DO. Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol 1999;94:2069-73. PMID 10445529.
  5. Tran T, Lowry A, El-Serag H (2007). "Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease drugs". Aliment Pharmacol Ther. 25 (2): 143–53. doi:10.1111/j.1365-2036.2006.03135.x. PMID 17229239.
  6. Decktor DL, Robinson M, Maton PN, Lanza FL, Gottlieb S. Effects of Aluminum/Magnesium Hydroxide and Calcium Carbonate on Esophageal and Gastric pH in Subjects with Heartburn. Am J Ther 1995;2:546-552. PMID 11854825.